Papel de la curcumina, resveratrol y ácido glicirricínico como agentes inmunomoduladores y antivirales en la salud animal. Revisión
DOI:
https://doi.org/10.22319/rmcp.v17i1.6865Palabras clave:
Polifenoles, Triterpenoides, Inmunomoduladores, Antivirales, AntiinflamatoriosResumen
En años recientes, el interés por estudiar compuestos de origen de vegetal para fines terapéuticos ha incrementado significativamente, impulsados por numerosos estudios que demuestran sus propiedades a nivel molecular, celular y fisiológico. Estos compuestos comúnmente presentes en la dieta de humanos y animales tienden a ser poco nocivos para el organismo. Particularmente, ciertos polifenoles como el resveratrol, la curcumina y los triterpenoides, como el ácido glicirricínico (GA), han mostrado cualidades prometedoras para la prevención y tratamiento de enfermedades infecciosas. Se ha demostrado que estos compuestos tienen efectos pleiotrópicos que permiten disminuir la carga de patógenos y mejorar las respuestas inmunológicas del organismo. Esta revisión aborda el papel fisiológico, inmunológico y antiviral del resveratrol, curcumina y GA, destacando su potencial uso en el tratamiento y control de enfermedades infecciosas, particularmente virales, y su posible aplicación en la salud animal. Adicionalmente, se describe la bioactividad de los compuestos en el organismo, destacando los hallazgos más relevantes, y puntualizando los efectos antivirales e inmunomoduladores de los compuestos para tratamiento y protección de enfermedades infecciosas virales.
Descargas
Citas
Lang Y, Gao N, Zang Z, Meng X, Lin Y, Yang S, Yang Y, Jin Z, Li B. Classification and antioxidant assays of polyphenols: A review. J Future Foods 2024;4(3):193-204. https://doi.org/10.1016/j.jfutfo.2023.07.002. DOI: https://doi.org/10.1016/j.jfutfo.2023.07.002
Islam T, Albracht-Schulte K, Ramalingam L, Schlabritz-Lutsevich N, Park OH, Zabet-Moghaddam M, Kalupahana NS, Moustaid-Moussa N. Anti-inflammatory mechanisms of polyphenols in adipose tissue: Role of gut microbiota, intestinal barrier integrity and zinc homeostasis. J Nutr Biochem 2023;(115):109242. https://doi.org/10.1016/j.jnutbio.2022.109242. DOI: https://doi.org/10.1016/j.jnutbio.2022.109242
Montenegro-Landívar MF, Tapia-Quirós P, Vecino X, Reig M, Valderrama C, Granados M, Cortina JL, Saurina J. Polyphenols and their potential role to fight viral diseases: An overview. Sci Total Environ 2021;(801):149719. https://doi.org/10.1016/j.scitotenv.2021.149719. DOI: https://doi.org/10.1016/j.scitotenv.2021.149719
Grosso G. Effects of polyphenol-rich foods on human health. Nutrients 2018;10(8):1089. https://doi.org/10.3390/nu10081089. DOI: https://doi.org/10.3390/nu10081089
Stover MG, Watson RR. Polyphenols in foods and dietary supplements. In: Polyphenols in human health and disease. 2014. Elsevier. https://doi.org/10.1016/B978-0-12-398456-2.00001-3. DOI: https://doi.org/10.1016/B978-0-12-398456-2.00001-3
Frei B, Higdon JV. Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr 2003;133(10):3275S-3284S. https://doi.org/10.1093/jn/133.10.3275S. DOI: https://doi.org/10.1093/jn/133.10.3275S
Gülçin İ. Antioxidant activity of food constituents: An overview. Arch Toxicol 2012;86(3):345-391. https://doi.org/10.1007/s00204-011-0774-2. DOI: https://doi.org/10.1007/s00204-011-0774-2
Francisco V, Costa G, Neves BM, Cruz MT, Batista MT. Anti-inflammatory activity of polyphenols on dendritic cells. In: Polyphenols: prevention and treatment of human disease. 2018:395-415. Elsevier. https://doi.org/10.1016/B978-0-12-813008-7.00031-X. DOI: https://doi.org/10.1016/B978-0-12-813008-7.00031-X
Constantinescu T, Mihis AG. Resveratrol as a privileged molecule with antioxidant activity. Food Chem 2023;(3):100539. https://doi.org/10.1016/j.focha.2023.100539 . DOI: https://doi.org/10.1016/j.focha.2023.100539
Braga A, Faria N. Biotechnological production of specialty aromatic and aromatic-derivative compounds. World J Microbiol Biotechnol 2022;38(5):80. https://doi.org/10.1007/s11274-022-03263-y. DOI: https://doi.org/10.1007/s11274-022-03263-y
Robertson I, Wai Hau T, Sami F, Sajid Ali M, Badgujar V, Murtuja S, et al. The science of resveratrol, formulation, pharmacokinetic barriers and its chemotherapeutic potential. Int J Pharm 2022;(618):121605. https://doi.org/10.1016/j.ijpharm.2022.121605. DOI: https://doi.org/10.1016/j.ijpharm.2022.121605
Wang X, Parvathaneni V, Shukla SK, Kulkarni NS, Muth A, Kunda NK, Gupta V. Inhalable resveratrol-cyclodextrin complex loaded biodegradable nanoparticles for enhanced efficacy against non-small cell lung cancer. Int J Biol Macromol 2020;(164):638-650. https://doi.org/10.1016/j.ijbiomac.2020.07.124. DOI: https://doi.org/10.1016/j.ijbiomac.2020.07.124
Calvo-Castro LA, Schiborr C, David F, Ehrt H, Voggel J, Sus N, Behnam D, Bosy-Westphal A, Frank J. The oral bioavailability of trans -resveratrol from a grapevine-shoot extract in healthy humans is significantly increased by micellar solubilization. Mol Nutr Food Res 2018;(62):1701057. DOI: https://doi.org/10.1002/mnfr.201701057
Su M, Dong C, Wan J, Zhou M. Pharmacokinetics, tissue distribution and excretion study of trans-resveratrol-3-O-glucoside and its two metabolites in rats. Phytomedicine 2019;(58):152882. https://doi.org/10.1016/j.phymed.2019.152882. DOI: https://doi.org/10.1016/j.phymed.2019.152882
Abba Y, Hassim H, Hamzah H, Noordin MM. Antiviral activity of resveratrol against human and animal viruses. Adv Virol 2015:1-7. https://doi.org/10.1155/2015/184241. DOI: https://doi.org/10.1155/2015/184241
Chen M, Chen X, Song X, Muhammad A, Jia R, Zou Y, et al. The immune-adjuvant activity and the mechanism of resveratrol on pseudorabies virus vaccine in a mouse model. Int Immunopharmacol 2019;(76):105876. https://doi.org/10.1016/j.intimp.2019.105876. DOI: https://doi.org/10.1016/j.intimp.2019.105876
Benedetti F, Sorrenti V, Buriani A, Fortinguerra S, Scapagnini G, Zella D. Resveratrol, rapamycin and metformin as modulators of antiviral pathways. Viruses 2020;12(12):1458. https://doi.org/10.3390/v12121458. DOI: https://doi.org/10.3390/v12121458
Wang X, Liu Y, Li K, Yang M, Wang Q, Hao Z. Triacetyl resveratrol inhibits PEDV by inducing the early apoptosis in vitro. Int J Mol Sci 2022;23(23):14499. https://doi.org/10.3390/ijms232314499. DOI: https://doi.org/10.3390/ijms232314499
Galindo I, Hernáez B, Berná J, Fenoll J, Cenis JL, Escribano JM, Alonso C. Comparative inhibitory activity of the stilbene’s resveratrol and oxyresveratrol on African swine fever virus replication. Antivir Res 2011;91(1):57–63. https://doi.org/10.1016/j.antiviral.2011.04.013. DOI: https://doi.org/10.1016/j.antiviral.2011.04.013
Chen X, Song X, Zhao X, Zhang Y, Wang Y, Jia R, Zou Y, Li L, Yin Z. Insights into the anti-inflammatory and antiviral mechanisms of resveratrol. Mediators Inflamm 2022:1-1. https://doi.org/10.1155/2022/7138756 . DOI: https://doi.org/10.1155/2022/7138756
Liu Y, Song D, Liu X, Wang Y, Wang G, Lan Y. Suppression of porcine hemagglutinating encephalomyelitis virus replication by resveratrol. Virol J 2022;19(1):226. https://doi.org/10.1186/s12985-022-01953-5. DOI: https://doi.org/10.1186/s12985-022-01953-5
Malaguarnera L. Influence of resveratrol on the immune response. Nutrients 2019;11(5):946. https://doi.org/10.3390/nu11050946. DOI: https://doi.org/10.3390/nu11050946
Harikumar KB, Aggarwal BB. Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 2008;7(8):1020–1035. https://doi.org/10.4161/cc.7.8.5740. DOI: https://doi.org/10.4161/cc.7.8.5740
Delmas D, Limagne E, Ghiringhelli F, Aires V. Immune Th17 lymphocytes play a critical role in the multiple beneficial properties of resveratrol. British Industrial Biological Research Association. 2020;(137):111091. https://doi.org/10.1016/j.fct.2019.111091. DOI: https://doi.org/10.1016/j.fct.2019.111091
Vasamsetti SB, Karnewar S, Gopoju R, Gollavilli PN, Narra SR, Kumar JM, Kotamraju, S. Resveratrol attenuates monocyte-to-macrophage differentiation and associated inflammation via modulation of intracellular GSH homeostasis: Relevance in atherosclerosis. Free Radic Biol Med 2016;(96):392–405. https://doi.org/10.1016/j.freeradbiomed.2016.05.003. DOI: https://doi.org/10.1016/j.freeradbiomed.2016.05.003
Kotha RR, Luthria DL. Curcumin: Biological, pharmaceutical, nutraceutical, and analytical aspects. Molecules 2019;24(16):2930. https://doi.org/10.3390/molecules24162930. DOI: https://doi.org/10.3390/molecules24162930
Fu YS, Chen TH, Weng L, Huang L, Lai D, Weng CF. Pharmacological properties and underlying mechanisms of curcumin and prospects in medicinal potential. Biomed Pharmacother 2021;(141):111888. https://doi.org/10.1016/j.biopha.2021.111888. DOI: https://doi.org/10.1016/j.biopha.2021.111888
Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: Problems and promises. Mol Pharm 2007;4(6):807-818. https://doi.org/10.1021/mp700113r. DOI: https://doi.org/10.1021/mp700113r
Ravindranath V, Chandrasekhara N. Absorption and tissue distribution of curcumin in rats. Toxicology 1980;16(3):259–265. https://doi.org/10.1016/0300-483x(80)90122-5. DOI: https://doi.org/10.1016/0300-483X(80)90122-5
Ravindranath V, Chandrasekhara N. Metabolism of curcumin--studies with [3H] curcumin. Toxicology 1981;22(4):337–344. https://doi.org/10.1016/0300-483x(81)90027-5. DOI: https://doi.org/10.1016/0300-483X(81)90027-5
Sharma RA, Ireson CR, Verschoyle RD, Hill KA, Williams ML, Leuratti C, et al. Effects of dietary curcumin on glutathione s-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: relationship with drug levels. Clin Cancer Res 2001;(7):1452-1458.
Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 1998;64(4):353–356. https://doi.org/10.1055/s-2006-957450. DOI: https://doi.org/10.1055/s-2006-957450
Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 2004;10(20):6847–6854. https://doi.org/10.1158/1078-0432.CCR-04-0744. DOI: https://doi.org/10.1158/1078-0432.CCR-04-0744
Ferreira VH, Nazli A, Dizzell SE, Mueller K, Kaushic C. The anti-inflammatory activity of curcumin protects the genital mucosal epithelial barrier from disruption and blocks replication of HIV-1 and HSV-2. PloS One 2015;10(4):e0124903. https://doi.org/10.1371/journal.pone.0124903. DOI: https://doi.org/10.1371/journal.pone.0124903
Nazli A, Chan O, Dobson-Belaire WN, Ouellet M, Tremblay MJ, Gray-Owen SD, et al. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog 2010;6(4):e1000852. https://doi.org/10.1371/journal.ppat.1000852, DOI: https://doi.org/10.1371/journal.ppat.1000852
Sui Z, Salto R, Li J, Craik C, Ortiz de Montellano PR. Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes. Bioorg Med Chem 1993;1(6):415–422. https://doi.org/10.1016/s0968-0896(00)82152-5. DOI: https://doi.org/10.1016/S0968-0896(00)82152-5
Mazumder A, Raghavan K, Weinstein J, Kohn KW, Pommier Y. Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmacol 1995;49(8):1165–1170. https://doi.org/10.1016/0006-2952(95)98514-a. DOI: https://doi.org/10.1016/0006-2952(95)98514-A
Mounce BC, Cesaro T, Carrau L, Vallet T, Vignuzzi M. Curcumin inhibits Zika and Chikungunya virus infection by inhibiting cell binding. Antivir Res 2017;(142):148–57. https://doi.org/10.1016/j.antiviral.2017.03.014. DOI: https://doi.org/10.1016/j.antiviral.2017.03.014
Chen DY, Shien JH, Tiley L, Chiou SS, Wang SY, et al. Curcumin inhibits influenza virus infection and haemagglutination activity. Food Chem 2010;(119):1346–135. https://doi.org/10.1016/j.foodchem.2009.09.011. DOI: https://doi.org/10.1016/j.foodchem.2009.09.011
Ou JL, Mizushina Y, Wang SY, Chuang DY, Nadar M, Hsu WL. Structure-activity relationship analysis of curcumin analogues on anti-influenza virus activity. FEBS J 2013;280(22):5829–5840. https://doi.org/10.1111/febs.12503. DOI: https://doi.org/10.1111/febs.12503
Dai J, Gu L, Su Y, Wang Q, Zhao Y, Chen X, Deng H, Li W, Wang G, Li K. Inhibition of curcumin on influenza A virus infection and influenzal pneumonia via oxidative stress, TLR2/4, p38/JNK MAPK and NF-κB pathways. Int Immunopharmacol 2018;(54):177–187. https://doi.org/10.1016/j.intimp.2017.11.009. DOI: https://doi.org/10.1016/j.intimp.2017.11.009
Chen TY, Chen D, Wen HW, Ou JL, Chiou SS, Chen JM, Wong ML, Hsu WL. Inhibition of enveloped viruses infectivity by curcumin. PloS One 2013;8(5):e62482. https://doi.org/10.1371/journal.pone.0062482. DOI: https://doi.org/10.1371/journal.pone.0062482
Li Y, Wang J, Liu Y, Luo X, Lei W, Xie L. Antiviral and virucidal effects of curcumin on transmissible gastroenteritis virus in vitro. J Gen Virol 2020;101(10):1079–1084. https://doi.org/10.1099/jgv.0.001466. DOI: https://doi.org/10.1099/jgv.0.001466
Praditya D, Kirchhoff L, Brüning J, Rachmawati H, Steinmann J, Steinmann E. Anti-infective properties of the golden spice curcumin. Front Microbiol 2019;(10):912. https://doi.org/10.3389/fmicb.2019.00912. DOI: https://doi.org/10.3389/fmicb.2019.00912
Varalakshmi Ch, Ali AM, Pardhasaradhi BVV, Srivastava RM, Singh S, Khar A. Immunomodulatory effects of curcumin: In-vivo. Int Immunopharmacol 2008;8(5): 688-00. https://doi.org/10.1016/j.intimp.2008.01.008. DOI: https://doi.org/10.1016/j.intimp.2008.01.008
Mohammadi A, Blesso CN, Barreto GE, Banach M, Majeed M, Sahebkar A. Macrophage plasticity, polarization and function in response to curcumin, a diet-derived polyphenol, as an immunomodulatory agent. J Nutr Biochem 2019;(66):1-16. https://doi.org/10.1016/j.jnutbio.2018.12.005. DOI: https://doi.org/10.1016/j.jnutbio.2018.12.005
Makuch S, Więcek K, Woźniak M. The immunomodulatory and anti-inflammatory effect of curcumin on immune cell populations, cytokines, and in vivo models of rheumatoid arthritis. Pharma 2021;14(4):309. https://doi.org/10.3390/ph14040309. DOI: https://doi.org/10.3390/ph14040309
Conigliaro P, Triggianese P, De Martino E, Fonti GL, Chimenti MS, Sunzini F, Viola A, Canofari C, Perricone R. Challenges in the treatment of rheumatoid arthritis. Autoimmun Rev 2019;18(7):706-713. https://doi.org/10.1016/j.autrev.2019.05.007. DOI: https://doi.org/10.1016/j.autrev.2019.05.007
Bright JJ. Curcumin and autoimmune disease. In: Aggarwal BB, Surh YJ, Shishodia S. The molecular targets and therapeutic uses of curcumin in health and disease. 2007:425-451. Springer US. https://doi.org/10.1007/978-0-387-46401-5_19. DOI: https://doi.org/10.1007/978-0-387-46401-5_19
Pandey P, Rane JS, Chatterjee A, Kumar A, Khan R, Prakash A, Ray S. Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: An in-silico study for drug development. J Biomol Struct Dyn 2021;39(16):6306-6316. https://doi.org/10.1080/07391102.2020.1796811. DOI: https://doi.org/10.1080/07391102.2020.1796811
Shen T, Jiang T, Long M, Chen J, Ren D-M, Wong PK, Chapman E, Zhou B, Zhang D. A curcumin derivative that inhibits vinyl carbamate-induced lung carcinogenesis via activation of the nrf2 protective response. Antioxid Redox Signa 2015;23(8):651-664. https://doi.org/10.1089/ars.2014.6074. DOI: https://doi.org/10.1089/ars.2014.6074
Da W, Zhang J, Zhang R, Zhu J. Curcumin inhibits the lymphangiogenesis of gastric cancer cells by inhibiton of HMGB1/VEGF-D signaling. Int J Immunopathol Pharmacol 2019;(33):205873841986160. https://doi.org/10.1177/2058738419861600. DOI: https://doi.org/10.1177/2058738419861600
Cheng K, Yang A, Hu X, Zhu D, Liu K. Curcumin attenuates pulmonary inflammation in lipopolysaccharide induced acute lung injury in neonatal rat model by activating peroxisome proliferator-activated receptor γ (pparγ) pathway. Med Sci Monit 2018;(24): 1178-1184. https://doi.org/10.12659/MSM.908714. DOI: https://doi.org/10.12659/MSM.908714
Abo‐Zaid MA, Shaheen ES, Ismail AH. Immunomodulatory effect of curcumin on hepatic cirrhosis in experimental rats. J Food Biochem 2020;44(6). https://doi.org/10.1111/jfbc.13219. DOI: https://doi.org/10.1111/jfbc.13219
Farzaei M, Zobeiri M, Parvizi F, El-Senduny F, Marmouzi I, Coy-Barrera E, Naseri R, Nabavi S, Rahimi R, Abdollahi M. Curcumin in liver diseases: a systematic review of the cellular mechanisms of oxidative stress and clinical perspective. Nutrients 2018;10(7):855. https://doi.org/10.3390/nu10070855. DOI: https://doi.org/10.3390/nu10070855
Pastorino G, Cornara L, Soares S, Rodrigues F, Oliveira MBPP. Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review. Phytother Res 2018;32(12): 2323-2339. DOI: https://doi.org/10.1002/ptr.6178
Selyutina OY, Polyakov NE. Glycyrrhizic acid as a multifunctional drug carrier – From physicochemical properties to biomedical applications: A modern insight on the ancient drug. Int J Pharm 2019;(559):271-279. DOI: https://doi.org/10.1016/j.ijpharm.2019.01.047
Polyakov NE. Glycyrrhizic acid as a novel drug delivery vector: synergy of drug transport and efficacy. Open Conf Proc J 2011;2(1):64-72. https://doi.org/10.2174/2210289201102010064.
Ming LJ, Yin AC. Therapeutic effects of glycyrrhizic acid. Nat Prod Commun 2013;8(3): 415–418. DOI: https://doi.org/10.1177/1934578X1300800335
Omar HR, Komarova I, El-Ghonemi M, Fathy A, Rashad R, Abdelmalak HD, et al. Licorice abuse: Time to send a warning message. Ther Adv Endocrinol Metab 2012;3(4):125-138. https://doi.org/10.1177/2042018812454322. DOI: https://doi.org/10.1177/2042018812454322
Final report on the safety assessment of glycyrrhetinic acid, potassium glycyrrhetinate, disodium succinoyl glycyrrhetinate, glyceryl glycyrrhetinate, glycyrrhetinyl stearate, stearyl glycyrrhetinate, glycyrrhizic acid, ammonium glycyrrhizate, dipotassium glycyrrhizate, disodium glycyrrhizate, trisodium glycyrrhizate, methyl glycyrrhizate, and potassium glycyrrhizinate. Int J Toxicol 2007;26(2):79-112. https://doi.org/10.1080/10915810701351228. DOI: https://doi.org/10.1080/10915810701351228
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP). (2015). Scientific opinion on the safety and efficacy of glycyrrhizic acid ammoniated (chemical group 30, miscellaneous substances) when used as a flavouring for all animal species. EFSA J 2015;13(1):3971. https://doi.org/10.2903/j.efsa.2015.3971. DOI: https://doi.org/10.2903/j.efsa.2015.3971
Hattori M, Sakamoto T, Yamagishi T, Sakamoto K, Konishi K, Kobashi K, Namba T. Metabolism of glycyrrhizin by human intestinal flora. II. Isolation and characterization of human intestinal bacteria capable of metabolizing glycyrrhizin and related compounds. Chem Pharm Bull 1985;33(1):210–217. https://doi.org/10.1248/cpb.33.210 DOI: https://doi.org/10.1248/cpb.33.210
Wang Z, Nishioka M, Kurosaki Y, Nakayama T, Kimura T. Gastrointestinal absorption characteristics of glycyrrhizin from glycyrrhiza extract. Biol Pharm Bull 1995;18(9): 1238–1241. https://doi.org/10.1248/bpb.18.1238. DOI: https://doi.org/10.1248/bpb.18.1238
Parke DV, Pollock S, Williams RT. The fate of tritium-labelled beta-glycyrrhetic acid in the rat. J Pharm Pharmacol 1963;(15):500–506. https://doi.org/10.1111/j.2042-7158.1963.tb12825.x. DOI: https://doi.org/10.1111/j.2042-7158.1963.tb12825.x
Ploeger B, Mensinga T, Sips A, Seinen W, Meulenbelt J, DeJongh J. The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling. Drug Metab Rev 2001;33(2):125–147. https://doi.org/10.1081/dmr-100104400. DOI: https://doi.org/10.1081/DMR-100104400
Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 2003;361(9374):2045–2046. https://doi.org/10.1016/s0140-6736(03)13615-x. DOI: https://doi.org/10.1016/S0140-6736(03)13615-X
Chen F, Chan KH, Jiang Y, Kao RY, Lu HT, Fan KW, et al. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J Clin Virol 2004; 31(1):69–75. https://doi.org/10.1016/j.jcv.2004.03.003. DOI: https://doi.org/10.1016/j.jcv.2004.03.003
Hoever G, Baltina L, Michaelis M, Kondratenko R, Baltina L, Tolstikov GA, Doerr HW, Cinatl J Jr. Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus. J Med Chem 2005;48(4):1256–1259. https://doi.org/10.1021/jm0493008. DOI: https://doi.org/10.1021/jm0493008
Lin JC. Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro. Antivir Res 2003;59(1):41–47. https://doi.org/10.1016/s0166-3542(03)00030-5. DOI: https://doi.org/10.1016/S0166-3542(03)00030-5
Baltina LA, Hour MJ, Liu YC, Chang YS, Huang SH, Lai HC, Kondratenko RM, Petrova SF, Yunusov MS, Lin CW. Antiviral activity of glycyrrhizic acid conjugates with amino acid esters against Zika virus. Virus Res 2021;(294):198290. https://doi.org/10.1016/j.virusres.2020.198290. DOI: https://doi.org/10.1016/j.virusres.2020.198290
Fiore C, Eisenhut M, Krausse R, Ragazzi E, Pellati D, Armanini D, Bielenberg J. Antiviral effects of Glycyrrhiza species. Phytother Res 2008;22(2):141–148. https://doi.org/10.1002/ptr.2295. DOI: https://doi.org/10.1002/ptr.2295
Li P, Zou H, Ren Y, Zarlenga DS, Ren X. Antiviral effect of diammonium glycyrrhizinate on cell infection by porcine parvovirus. Curr Microbiol 2014;69(1):82–87. https://doi.org/10.1007/s00284-014-0540-9. DOI: https://doi.org/10.1007/s00284-014-0540-9
Gao R, Zhang Y, Kang Y, Xu W, Jiang L, Guo T, Huan C. Glycyrrhizin Inhibits PEDV Infection and proinflammatory cytokine secretion via the HMGB1/TLR4-MAPK p38 pathway. Int J Mol Sci 2020;21(8):2961. https://doi.org/10.3390/ijms21082961. DOI: https://doi.org/10.3390/ijms21082961
Huo X, Sun X, Cao Z, Qiao J, Yang S, Meng X, Zhao Y. Optimal ratio of 18α‑ and 18β‑glycyrrhizic acid for preventing alcoholic hepatitis in rats. Exp Ther Med 2019;18(1):172-178. https://doi.org/10.3892/etm.2019.7572. DOI: https://doi.org/10.3892/etm.2019.7572
Xie C, Li X, Wu J, Liang Z, Deng F, Xie W, Zhu M, Zhu J, Zhu W, Geng S, Zhong C. Anti-inflammatory activity of magnesium isoglycyrrhizinate through inhibition of phospholipase a2/arachidonic acid pathway. Inflammation 2015;38(4):1639-1648. https://doi.org/10.1007/s10753-015-0140-2. DOI: https://doi.org/10.1007/s10753-015-0140-2
Yang R, Yuan B-C, Ma Y-S, Zhou S, Liu Y. The anti-inflammatory activity of licorice, a widely used Chinese herb. Pharm Biol 2017;55(1):5-18. https://doi.org/10.1080/13880209.2016.1225775. DOI: https://doi.org/10.1080/13880209.2016.1225775
Ma D, Zhang J, Zhang Y, Zhang X, Han X, Song T, Zhang Y, Chu L. Inhibition of myocardial hypertrophy by magnesium isoglycyrrhizinate through the TLR4/NF-κB signaling pathway in mice. Int Immunopharmacol 2018;(55):237-244. https://doi.org/10.1016/j.intimp.2017.12.019. DOI: https://doi.org/10.1016/j.intimp.2017.12.019
Zhao L, Ju-ying Z, Er-ning G, Hong Y. Effects of glycyrrhizin acid and licorice flavonoids on LPS-induced cytokines expression in macrophage. Zhongguo Zhong Yao Za Zhi 2014;39(19).
Dai JH, Iwatani Y, Ishida T, Terunuma H, Kasai H, Iwakula Y, Fujiwara H, Ito M. Glycyrrhizin enhances interleukin‐12 production in peritoneal macrophages. Immunology 2001;103(2):235-243. https://doi.org/10.1046/j.1365-2567.2001.01224.x. DOI: https://doi.org/10.1046/j.1365-2567.2001.01224.x
Bhattacharjee S, Bhattacharjee A, Majumder S, Majumdar SB, Majumdar S. Glycyrrhizic acid suppresses Cox-2-mediated anti-inflammatory responses during Leishmania donovani infection. J Antimicrob Chemother 2012;67(8):1905-1914. https://doi.org/10.1093/jac/dks159. DOI: https://doi.org/10.1093/jac/dks159
Bordbar N, Karimi MH, Amirghofran Z. The effect of glycyrrhizin on maturation and T cell stimulating activity of dendritic cells. Cell Immunol, 2012; 280(1):44-49. https://doi.org/10.1016/j.cellimm.2012.11.013 DOI: https://doi.org/10.1016/j.cellimm.2012.11.013
Richard SA. Exploring the pivotal immunomodulatory and anti-inflammatory potentials of glycyrrhizic and glycyrrhetinic acids. Med Inflamm 2021:1-15. https://doi.org/10.1155/2021/6699560. DOI: https://doi.org/10.1155/2021/6699560
Scott MB, Styring AK, McCullagh JSO. Polyphenols: bioavailability, microbiome interactions and cellular effects on health in humans and animals. Pathogens 2022;11(7): 770. https://doi.org/10.3390/pathogens11070770. DOI: https://doi.org/10.3390/pathogens11070770
Sampathkumar KTKX, Loo SCJ. Developing nano-delivery systems for agriculture and food applications with nature-derived polymers. iScience 2020;23(5):101055. https://doi.org/10.1016/j.isci.2020.101055. DOI: https://doi.org/10.1016/j.isci.2020.101055
Adepu S, Ramakrishna S. Controlled drug delivery systems: current status and future directions. Molecules 2021;26(19):5905. https://doi.org/10.3390/molecules26195905. DOI: https://doi.org/10.3390/molecules26195905
Ding Y, Li Z, Jaklenec A, Hu Q. Vaccine delivery systems toward lymph nodes. Adv Drug Deliv Rev 2021;(179):113914. https://doi.org/10.1016/j.addr.2021.113914. DOI: https://doi.org/10.1016/j.addr.2021.113914
Jia W, Zhou L, Li L, Zhou P, Shen Z. Nano-based drug delivery of polyphenolic compounds for cancer treatment: progress, opportunities, and challenges. Pharmaceuticals 2023;16(1):101. https://doi.org/10.3390/ph16010101. DOI: https://doi.org/10.3390/ph16010101
Vasconcelos T, Araújo F, Lopes C, Loureiro A, das Neves J, Marques S, Sarmento B. Multicomponent self-nano emulsifying delivery systems of resveratrol with enhanced pharmacokinetics profile. Eur J Pharm Sci 2019;(137):105011. https://doi.org/10.1016/j.ejps.2019.105011. DOI: https://doi.org/10.1016/j.ejps.2019.105011
Bohara RA, Tabassum N, Singh MP, Gigli G, Ragusa A, Leporatti S. Recent overview of resveratrol's beneficial effects and its nano-delivery systems. Molecules 2022;27(16):5154. https://doi.org/10.3390/molecules27165154. DOI: https://doi.org/10.3390/molecules27165154
Singh G. Resveratrol: nanocarrier-based delivery systems to enhance its therapeutic potential. Nanomedicine 2020;15(28):2801–2817. https://doi.org/10.2217/nnm-2020-0289. DOI: https://doi.org/10.2217/nnm-2020-0289
Meng Q, Li J, Wang C, Shan A. Biological function of resveratrol and its application in animal production: a review. J Anim Sci Biotechnol 2023;14(1):25. https://doi.org/10.1186/s40104-022-00822-z. DOI: https://doi.org/10.1186/s40104-022-00822-z
Gan Z, Wei W, Li Y, Wu J, Zhao Y, Zhang L, Wang T, Zhong X. Curcumin and resveratrol regulate intestinal bacteria and alleviate intestinal inflammation in weaned piglets. Molecules 2019;(24):1220. https://doi.org/10.3390/molecules24071220. DOI: https://doi.org/10.3390/molecules24071220
Dei Cas M, Ghidoni R. Dietary curcumin: Correlation between bioavailability and health potential. Nutrients 2019;11(9):2147. https://doi.org/10.3390/nu11092147. DOI: https://doi.org/10.3390/nu11092147
Józsa L, Vasvári G, Sinka D, Nemes D, Ujhelyi Z, Vecsernyés M, et al. Enhanced antioxidant and anti-inflammatory effects of self-nano and microemulsifying drug delivery systems containing curcumin. Molecules 2022;27(19):6652. https://doi.org/10.3390/molecules27196652. DOI: https://doi.org/10.3390/molecules27196652
Witika BA, Makoni PA, Matafwali SK, Mweetwa LL, Shandele GC, Walker RB. Enhancement of biological and pharmacological properties of an encapsulated polyphenol: curcumin. Molecules 2021;26(14):4244. https://doi.org/10.3390/molecules26144244. DOI: https://doi.org/10.3390/molecules26144244
Kharat M, McClements DJ. Recent advances in colloidal delivery systems for nutraceuticals: A case study - Delivery by design of curcumin. J Colloid Interface Sci 2019;(557):506–518. https://doi.org/10.1016/j.jcis.2019.09.045. DOI: https://doi.org/10.1016/j.jcis.2019.09.045
Huang M, Zhai BT, Fan Y, Sun J, Shi YJ, Zhang XF, Zou JB, Wang JW, Guo DY. Targeted drug delivery systems for curcumin in breast cancer therapy. Int J Nanomed 2023;(18):4275–4311. https://doi.org/10.2147/IJN.S410688. DOI: https://doi.org/10.2147/IJN.S410688
Liu T, Zhu W, Han C, Sui X, Liu C, Ma X, Dong Y. Preparation of glycyrrhetinic acid liposomes using lyophilization monophase solution method: Preformulation, optimization, and in vitro evaluation. Nanoscale Res Lett 2018;13(1):324. https://doi.org/10.1186/s11671-018-2737-5. DOI: https://doi.org/10.1186/s11671-018-2737-5
Polyakov NE. Glycyrrhizic acid as a novel drug delivery vector: synergy of drug transport and efficacy. OCP 2011;2(1):64-72. https://doi.org/10.2174/2210289201102010064. DOI: https://doi.org/10.2174/2210289201102010064
Zhao X, Liu J, Hu Y, Fan Y, Wang D, Yuan J, Xu L, Cui L, Jing Z. Optimization on condition of glycyrrhetinic acid liposome by RSM and the research of its immunological activity. Int J Biol Macromol 2012;51(3):299–304. https://doi.org/10.1016/j.ijbiomac.2012.05.005. DOI: https://doi.org/10.1016/j.ijbiomac.2012.05.005
Dionigi L, Ragonese F, Monarca L, Covino S, de Luca A, Iannitti RG, et al. Focus on the use of resveratrol as an adjuvant in glioblastoma therapy. Curr Pharm Des 2020;26(18): 2102–2108. https://doi.org/10.2174/1381612826666200401085634. DOI: https://doi.org/10.2174/1381612826666200401085634
Mortezaee K, Najafi M, Farhood B, Ahmadi A, Shabeeb D, Musa AE. Resveratrol as an adjuvant for normal tissues protection and tumor sensitization. Curr Cancer Drug Targets 2020;20(2):130–145. https://doi.org/10.2174/1568009619666191019143539. DOI: https://doi.org/10.2174/1568009619666191019143539
Delmas D, Lin HY. Role of membrane dynamics processes and exogenous molecules in cellular resveratrol uptake: consequences in bioavailability and activities. Mol Nutr Food Res 2011;55(8):1142–1153. https://doi.org/10.1002/mnfr.201100065. DOI: https://doi.org/10.1002/mnfr.201100065
Alesci A, Nicosia N, Fumia A, Giorgianni F, Santini A, Cicero N. Resveratrol and immune cells: A link to improve human health. Molecules 2022;27(2):424. https://doi.org/10.3390/molecules27020424. DOI: https://doi.org/10.3390/molecules27020424
Maithilikarpagaselvi N, Sridhar MG, Swaminathan RP, Sripradha R, Badhe B. Curcumin inhibits hyperlipidemia and hepatic fat accumulation in high-fructose-fed male Wistar rats. Pharm Biol 2016;54(12):2857–2863. https://doi.org/10.1080/13880209.2016.1187179. DOI: https://doi.org/10.1080/13880209.2016.1187179
Huang G, Xu Z, Huang Y, Duan X, Gong W, Zhang Y, Fan J, He F. Curcumin protects against collagen-induced arthritis via suppression of BAFF production. J Clin Immunol 2013;33(3):550–557. https://doi.org/10.1007/s10875-012-9839-0. DOI: https://doi.org/10.1007/s10875-012-9839-0
Zhao HM, Xu R, Huang XY, Cheng SM, Huang MF, Yue HY, Wang X, Zou Y, Lu AP, Liu DY. Curcumin improves regulatory T cells in gut-associated lymphoid tissue of colitis mice. World J Gastroenterol 2016;22(23):5374–5383. https://doi.org/10.3748/wjg.v22.i23.5374. DOI: https://doi.org/10.3748/wjg.v22.i23.5374
Zhao X, Fan Y, Wang D, Hu Y, Guo L, Ruan S, Zhang J, Yuan J. Immunological adjuvant efficacy of glycyrrhetinic acid liposome against Newcastle disease vaccine. Vaccine, 2011;29(52):9611–9617. https://doi.org/10.1016/j.vaccine.2011.10.053. DOI: https://doi.org/10.1016/j.vaccine.2011.10.053
Castañeda-Montes MA, Cuevas-Romero JS, Cerriteño-Sánchez JL, de María Ávila-De la Vega L, García-Cambrón JB, Ramírez-Álvarez H. Small ruminant lentivirus capsid protein (SRLV-p25) antigenic structural prediction and immunogenicity to recombinant SRLV-rp25-coupled to immunostimulatory complexes based on glycyrrhizinic acid. BBB 2023;87(3):267–278. https://doi.org/10.1093/bbb/zbac206. DOI: https://doi.org/10.1093/bbb/zbac206
García-Cambrón JB, Cerriteño-Sánchez JL, Lara-Romero R, Quintanar-Guerrero D, Blancas-Flores G, Sánchez-Gaytán BL, et al. Development of glycyrrhizinic acid-based lipid nanoparticle (LNP-GA) as an adjuvant that improves the immune response to porcine epidemic diarrhea virus spike recombinant protein. Viruses 2024;16(3):431. https://doi.org/10.3390/v16030431. DOI: https://doi.org/10.3390/v16030431
Descargas
Publicado
Cómo citar
-
Resumen99
-
PDF51
-
PDF 46
-
Texto completo22
-
Full text 17
Número
Sección
Licencia
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Los autores/as que publiquen en la Revista Mexicana de Ciencias Pecuarias aceptan las siguientes condiciones:
De acuerdo con la legislación de derechos de autor, la Revista Mexicana de Ciencias Pecuarias reconoce y respeta el derecho moral de los autores/as, así como la titularidad del derecho patrimonial, el cual será cedido a la revista para su difusión en acceso abierto.
Esta obra está bajo una Licencia Creative Commons Atribución-NoComercial-CompartirIgual 4.0 Internacional.
